Novel Therapies for Metastatic Non-Small Cell Lung Cancer with MET Exon 14 Alterations: A Spotlight on Capmatinib
Aaron C Tan,1 Tracy J Loh,2 Xue Lin Kwang,1 Gek San Tan,2 Kiat Hon Lim,2 Daniel SW Tan1 1Division of Medical Oncology, National Cancer Centre Singapore, Singapore, 169610, Singapore; 2Department of Pathology, Singapore General Hospital, Singapore, 169608, SingaporeCorrespondence: Daniel SW TanNation...
Saved in:
Main Authors: | Tan AC, Loh TJ, Kwang XL, Tan GS, Lim KH, Tan DSW |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/031f63eddb764d4ebbf865c25b2d833d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeted Treatment of Non-Small Cell Lung Cancer: Focus on Capmatinib with Companion Diagnostics
by: Guo MZ, et al.
Published: (2021) -
Lung Cancer with MET exon 14 Skipping Mutation: Genetic Feature, Current Treatments, and Future Challenges
by: Fujino T, et al.
Published: (2021) -
Therapeutic Prospects of Exon Skipping for Epidermolysis Bullosa
by: Franciscus C. Vermeer, et al.
Published: (2021) -
Spotlight on Mobocertinib (TAK-788) in NSCLC with EGFR Exon 20 Insertion Mutations
by: Zhang SS, et al.
Published: (2021) -
Case Report: A Synonymous Mutation in NF1 Located at the Non-canonical Splicing Site Leading to Exon 45 Skipping
by: Pengzhen Jin, et al.
Published: (2021)